AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Pacira BioSciences has issued inducement grants to new employees under its Amended and Restated 2014 Inducement Plan. The company operates in the healthcare sector, focusing on non-opioid pain management solutions. Pacira's financial health shows a mix of strengths and challenges, with a gross margin of 79.17% and a Z-Score indicating financial stress. The company's revenue growth has been steady at 8.5% over the past three years.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet